Tissue-specific expression of c-Ha-ras in premalignant gastrointestinal mucosae

Exp Mol Pathol. 1989 Dec;51(3):264-74. doi: 10.1016/0014-4800(89)90024-5.

Abstract

The molecular mechanisms underlying premalignant gastrointestinal diseases, such as ulcerative colitis and Barrett's esophagus, remain unknown. For this reason, the expression of the protooncogene c-Ha-ras was studied in ulcerative colitis and Barrett's esophagus. Total cellular RNA was extracted from different regions of the gastrointestinal tract in these two diseases. Expression of c-Ha-ras was greater in proximal than in distal colon and undetectable in Barrett's esophagus. These regional differences in expression were not seen with the control gene beta-actin or with the protooncogenes c-myc and p53. In order to evaluate structural factors contributing to expression, amplification and methylation of c-Ha-ras DNA were studied in these tissues by Southern and slot blotting. No amplification of c-Ha-ras or six other protooncogenes was detected. These data suggest tissue-specific regulation of c-Ha-ras expression in the gastrointestinal tract in certain premalignant disease states.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenomatous Polyposis Coli / genetics*
  • Barrett Esophagus / genetics*
  • Colitis, Ulcerative / genetics*
  • Colon / physiology
  • Gene Amplification
  • Humans
  • Intestinal Mucosa / pathology
  • Intestinal Mucosa / physiology*
  • Methylation
  • Oncogene Protein p21(ras) / genetics*
  • Oncogene Proteins / genetics
  • Phosphoproteins / genetics
  • Precancerous Conditions / genetics
  • Proto-Oncogene Proteins / genetics
  • Proto-Oncogene Proteins c-myc
  • Proto-Oncogenes*
  • Tumor Suppressor Protein p53

Substances

  • Oncogene Proteins
  • Phosphoproteins
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-myc
  • Tumor Suppressor Protein p53
  • Oncogene Protein p21(ras)